Evidence map›Paper›PMID 31379531›Full record

ArticleFrontiers in behavioral neuroscience2019

Varenicline Targets the Reinforcing-Enhancing Effect of Nicotine on Its Associated Salient Cue During Nicotine Self-administration in the Rat.

Vernon Garcia-Rivas, Jean-François Fiancette, Nazzareno Cannella, Maria Carbo-Gas, Prisca Renault, Jessica Tostain, Véronique Deroche-Gamonet

Open access · goldAbstract read
In one paragraph

Article in Frontiers in behavioral neuroscience, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Vernon Garcia-RivasPsychobiology of Drug Addiction, NeuroCentre Magendie, INSERM U1215, Bordeaux, France.
Jean-François FiancettePsychobiology of Drug Addiction, NeuroCentre Magendie, INSERM U1215, Bordeaux, France.
Nazzareno CannellaPsychobiology of Drug Addiction, NeuroCentre Magendie, INSERM U1215, Bordeaux, France.
Maria Carbo-GasPsychobiology of Drug Addiction, NeuroCentre Magendie, INSERM U1215, Bordeaux, France.
Prisca RenaultPsychobiology of Drug Addiction, NeuroCentre Magendie, INSERM U1215, Bordeaux, France.
Jessica TostainPsychobiology of Drug Addiction, NeuroCentre Magendie, INSERM U1215, Bordeaux, France.
Véronique Deroche-GamonetPsychobiology of Drug Addiction, NeuroCentre Magendie, INSERM U1215, Bordeaux, France.
Inserm · FRNeurocentre Magendie · FRUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nicotine is acknowledged as the key addictive compound of tobacco. Varenicline (Champix

Indexed as

cuesindividual differencesintravenous self-administrationnicotineratvarenicline

Identifiers

PMID31379531
PMCPMC6650579
OpenAlexW2959358923

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.